OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi, Ed Reznik, Chung‐Han Lee, et al.
Cancer Cell (2016) Vol. 29, Iss. 1, pp. 104-116
Open Access | Times Cited: 660
A. Ari Hakimi, Ed Reznik, Chung‐Han Lee, et al.
Cancer Cell (2016) Vol. 29, Iss. 1, pp. 104-116
Open Access | Times Cited: 660
Showing 1-25 of 660 citing articles:
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Cell Reports (2017) Vol. 18, Iss. 1, pp. 248-262
Open Access | Times Cited: 3731
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Cell Reports (2017) Vol. 18, Iss. 1, pp. 248-262
Open Access | Times Cited: 3731
Renal cell carcinoma
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 2110
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 2110
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden, Ralph J. DeBerardinis
Cell (2017) Vol. 168, Iss. 4, pp. 657-669
Open Access | Times Cited: 1908
Matthew G. Vander Heiden, Ralph J. DeBerardinis
Cell (2017) Vol. 168, Iss. 4, pp. 657-669
Open Access | Times Cited: 1908
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal, M. Celeste Simon
The Journal of Cell Biology (2018) Vol. 217, Iss. 7, pp. 2291-2298
Open Access | Times Cited: 1010
Ankita Bansal, M. Celeste Simon
The Journal of Cell Biology (2018) Vol. 217, Iss. 7, pp. 2291-2298
Open Access | Times Cited: 1010
Identification of bioactive metabolites using activity metabolomics
Markus M. Rinschen, Julijana Ivanišević, Martin Giera, et al.
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 6, pp. 353-367
Open Access | Times Cited: 827
Markus M. Rinschen, Julijana Ivanišević, Martin Giera, et al.
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 6, pp. 353-367
Open Access | Times Cited: 827
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer, et al.
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 815
Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer, et al.
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 815
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David Clark, Saravana M. Dhanasekaran, Francesca Petralia, et al.
Cell (2019) Vol. 179, Iss. 4, pp. 964-983.e31
Open Access | Times Cited: 577
David Clark, Saravana M. Dhanasekaran, Francesca Petralia, et al.
Cell (2019) Vol. 179, Iss. 4, pp. 964-983.e31
Open Access | Times Cited: 577
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Jiyeon Kim, Ralph J. DeBerardinis
Cell Metabolism (2019) Vol. 30, Iss. 3, pp. 434-446
Open Access | Times Cited: 478
Jiyeon Kim, Ralph J. DeBerardinis
Cell Metabolism (2019) Vol. 30, Iss. 3, pp. 434-446
Open Access | Times Cited: 478
Metabolic reprogramming in clear cell renal cell carcinoma
Hiromi I. Wettersten, Omran Abu Aboud, Primo N. Lara, et al.
Nature Reviews Nephrology (2017) Vol. 13, Iss. 7, pp. 410-419
Closed Access | Times Cited: 422
Hiromi I. Wettersten, Omran Abu Aboud, Primo N. Lara, et al.
Nature Reviews Nephrology (2017) Vol. 13, Iss. 7, pp. 410-419
Closed Access | Times Cited: 422
Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 417
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 417
Metabolic landscape of the tumor microenvironment at single cell resolution
Zhengtao Xiao, Ziwei Dai, Jason W. Locasale
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 399
Zhengtao Xiao, Ziwei Dai, Jason W. Locasale
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 399
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Weinan Du, Luchang Zhang, Adina Brett-Morris, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 368
Weinan Du, Luchang Zhang, Adina Brett-Morris, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 368
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan, Dan Y. Gui, Matthew G. Vander Heiden
Nature reviews. Cancer (2016) Vol. 16, Iss. 11, pp. 680-693
Closed Access | Times Cited: 356
Lucas B. Sullivan, Dan Y. Gui, Matthew G. Vander Heiden
Nature reviews. Cancer (2016) Vol. 16, Iss. 11, pp. 680-693
Closed Access | Times Cited: 356
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Yue Gong, Peng Ji, Yun‐Song Yang, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 51-64.e9
Open Access | Times Cited: 339
Yue Gong, Peng Ji, Yun‐Song Yang, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 51-64.e9
Open Access | Times Cited: 339
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 334
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 334
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Fan Yang, Yi Xiao, Jia-Han Ding, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 84-100.e8
Open Access | Times Cited: 326
Fan Yang, Yi Xiao, Jia-Han Ding, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 84-100.e8
Open Access | Times Cited: 326
Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
Edoardo Gaude, Christian Frezza
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 325
Edoardo Gaude, Christian Frezza
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 325
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Lynda Vuong, Ritesh R. Kotecha, Martin H. Voss, et al.
Cancer Discovery (2019) Vol. 9, Iss. 10, pp. 1349-1357
Open Access | Times Cited: 321
Lynda Vuong, Ritesh R. Kotecha, Martin H. Voss, et al.
Cancer Discovery (2019) Vol. 9, Iss. 10, pp. 1349-1357
Open Access | Times Cited: 321
Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets
Dinesh Kumar Barupal, Oliver Fiehn
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 317
Dinesh Kumar Barupal, Oliver Fiehn
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 317
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2016)
Open Access | Times Cited: 308
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2016)
Open Access | Times Cited: 308
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
Heike Miess, Beatrice Dankworth, Arvin M. Gouw, et al.
Oncogene (2018) Vol. 37, Iss. 40, pp. 5435-5450
Open Access | Times Cited: 296
Heike Miess, Beatrice Dankworth, Arvin M. Gouw, et al.
Oncogene (2018) Vol. 37, Iss. 40, pp. 5435-5450
Open Access | Times Cited: 296
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Xinxin Peng, Zhongyuan Chen, Farshad Farshidfar, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 255-269.e4
Open Access | Times Cited: 263
Xinxin Peng, Zhongyuan Chen, Farshad Farshidfar, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 255-269.e4
Open Access | Times Cited: 263
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 260
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 260
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D. Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Cell Metabolism (2018) Vol. 28, Iss. 5, pp. 793-800.e2
Open Access | Times Cited: 241
Kevin D. Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Cell Metabolism (2018) Vol. 28, Iss. 5, pp. 793-800.e2
Open Access | Times Cited: 241
The Metabolic Basis of Kidney Cancer
W. Marston Linehan, Laura S. Schmidt, Daniel R. Crooks, et al.
Cancer Discovery (2019) Vol. 9, Iss. 8, pp. 1006-1021
Open Access | Times Cited: 231
W. Marston Linehan, Laura S. Schmidt, Daniel R. Crooks, et al.
Cancer Discovery (2019) Vol. 9, Iss. 8, pp. 1006-1021
Open Access | Times Cited: 231
